Article
Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Aug 2002
Kiviharju Taija M, Lecane Philip S, Sellers Robert G, Peehl Donna M
Abstract excerpt
Interest in exploiting traditional medicines for prevention or treatment of cancer is increasing. Extracts from the herb Tripterygium wilfordii hook F have been used in China for centuries to treat immune-related disorders. Recently it was reported that triptolide (PG490), a purified compound from Tripterygium, possessed antitumor properties and induced apoptosis by p53-independent mechanisms in a variety of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
